Tag: inhibitor
New Drug Application of Desidustat Tablets Accepted in China
Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney disease patients. The Product is administrated orally, thus expecting to...
Top News
Breaking News
2023 League of Legends Worlds Quarterfinals Bilibili Gaming vs Gen.G
2023 League of Legends Worlds Quarterfinals Weibo vs. NRG Recap by s. samek It’s the second quarterfinal matchup at Worlds 2023. Gen.G faces...
China Pharmaceutical Competitive Landscape and Drugs Pipeline Analysis Report 2023: Business Overview of 330 Companies, 1500 Drugs in Trials, & 200 Commercially Approved Drugs...
DUBLIN–(BUSINESS WIRE)–The “China Pharmaceutical Companies and Drugs Pipeline Insight 2023” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Chinese drugs makers have advanced significantly in...
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results
HONG KONG, Aug 25, 2023 - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical...
A Drug Designed by AI Is Starting Its First Human Trials
Four years ago, biotech company Insilico Medicine used AI to design a molecule targeting a protein involved in fibrosis in just 46 days. It...
In a First, an AI-Designed Drug Is Being Tested in Humans to See if It Actually Works
Four years ago, biotech company Insilico Medicine used AI to design a molecule targeting a protein involved in fibrosis in just 46 days. It...
How 3D Changes in the Genome Turned Sharks Into Skates | Quanta Magazine
IntroductionThe marine creatures called skates skim along the sea bottom, rippling their winglike pectoral fins to propel themselves and to stir up small creatures...
Wild Rift patch 4.2 notes: Swain release, ADC revamp, and more
Wild Rift patch 4.2 is finally here — meaning Swain released as well. And with the release of the big patch, Wild Rift massively...
Sino Biopharm (1177.HK) Announces 2022 Annual Results
HONG KONG, Mar 31, 2023 - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical...
On-Demand Male Birth Control Immobilizes Sperm and Completely Wears Off in a Day
Late last year, a Virginia-based startup called Contraline started the initial clinical trial of its male birth control, a hydrogel that’s injected directly into...
The Cause of Depression Is Probably Not What You Think
IntroductionPeople often think they know what causes chronic depression. Surveys indicate that more than 80% of the public blames a “chemical imbalance” in the...
Inotrem Receives Funding From the Crohn’s & Colitis Foundation to Help Develop New Therapeutic Approaches in Inflammatory Bowel Disease (IBD)
The funding will support the development of INO-02 a new long-acting therapeutic approach to modulate the TREM-1 pathway.
PARIS–(BUSINESS WIRE)–#IBD—Inotrem, an advanced clinical stage biotech...
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics
— Agreement Covers Buyout of Remaining Financial Obligations for Anti-CCR8 Antibody in Development as a Potential Treatment for Solid Tumors —
FOSTER CITY, Calif. &...
Latest Intelligence
